trending Market Intelligence /marketintelligence/en/news-insights/trending/DvaQTw4kHUzqHclt9u7Otw2 content esgSubNav
In This List

Blueprint Medicines closes $325.5M common stock offering

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Blueprint Medicines closes $325.5M common stock offering

Blueprint Medicines Corp. closed its public offering of common stock and raised about $325.5 million in net proceeds.

The company sold 4,259,259 common shares at $81.00 per share, which included the underwriters' full exercise of their option to buy additional shares.

Goldman Sachs & Co. LLC, Morgan Stanley and Cowen acted as joint book-running managers, while Canaccord Genuity acted as co-manager for the offering.